Igama leGeneric: | Semaglutide |
Inombolo yeCas: | 910463-68-2 |
Ifomula yeemolekyuli: | C187H291N45O59 |
Ubunzima bemolekyuli: | 4113.641 g/mol |
Ulandelelwano: | -His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(AEEAc-AEEAc-γ-Glu-17) -carboxyheptadecanoyl)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH |
Imbonakalo: | Umgubo omhlophe |
Isicelo: | I-Semaglutide liyeza elisetyenziselwa ukunyanga uhlobo lwe-2 yeswekile. Yeyodidi lweziyobisi ezibizwa ngokuba yi-GLP-1 receptor agonists, ezisebenza ngokunyusa ukukhutshwa kwe-insulin kunye nokunciphisa ukuveliswa kweglucose esibindini. I-Semaglutide ijojowe kanye ngeveki kwaye ibonakaliswe kwizilingo zeklinikhi ukwehlisa ngokufanelekileyo amanqanaba eshukela egazi. Ukongezelela, idibaniswe nokulahlekelwa kwesisindo kunye nokuphucula iziphumo ze-cardiovascular. I-Semaglutide ngokuqhelekileyo inyamezeleke kakuhle, kodwa ezinye izigulane zinokufumana imiphumo emibi efana ne-nausea, ukuhlanza okanye isifo sohudo. Izigulane kufuneka zixoxe ngazo zonke iziphumo ezichaphazelekayo kunye neengozi kunye nomboneleli wabo wezempilo ngaphambi kokuthatha i-semaglutide. Kubalulekile ukuba uqaphele ukuba i-semaglutide ayifanele isetyenziswe ukuphatha uhlobo lwe-1 yeswekile okanye i-diabetic ketoacidosis. |
Umqulu: | ibhegi yefoyile ye-aluminiyam okanye i-TIN ye-aluminium okanye ngokweemfuno zomthengi |
1 | Umthengisi oqeqeshiweyo we-peptide APIs evela eTshayina. |
2 | Imigca yemveliso eyi-16 enomthamo omkhulu owaneleyo wemveliso kunye nexabiso elikhuphisanayo |
3 | I-GMP kunye ne-DMF zifumaneka ngowona maxwebhu athembekileyo. |
A: Ewe, singapakisha njengemfuno yakho.
A: I-LC sight kunye ne-TT kwithuba lokuhlawula kwangaphambili elikhethwayo.
IMPENDULO: Ewe, nceda unikezele ngeenkcukacha zomgangatho wakho, siza kujonga kwi-R&D yethu kwaye sizame ukungqamanisa ubunjani bakho.